AstraZeneca drug combination on track to fight lung cancer
May 13, 2015 at 17:00 PM EDT
May 13 (Reuters) - A closely watched immune system-boosting drug cocktail from Britain's AstraZeneca shows promise in advanced lung cancer, despite adverse side effects in a number of patients.
